We are live on ! Find out more
ARTL icon

Artelo Biosciences
ARTL

15 hedge funds and large institutions have $1.57M invested in Artelo Biosciences in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.01% less ownership

Funds ownership: 0.04% → 0.03% (-0.01%)

6% less funds holding

Funds holding: 16 → 15 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

52% less capital invested

Capital invested by funds: $3.29M → $1.57M (-$1.72M)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$47.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.8K
3
VF
Virtu Financial
New York
+$19.1K
4
HighTower Advisors
HighTower Advisors
Illinois
+$9.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.35K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$258K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$211K
3
Two Sigma Investments
Two Sigma Investments
New York
-$195K
4
BFM
Boothbay Fund Management
New York
-$112K
5
Citadel Advisors
Citadel Advisors
Florida
-$43.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$687K +$5.33K +21 +0.7%
Renaissance Technologies
2
Renaissance Technologies
New York
$223K -$258K -1,015 -49%
KC
3
Kepos Capital
New York
$158K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$128K +$20.8K +82 +16%
BFM
5
Boothbay Fund Management
New York
$97K -$112K -441 -49%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$68K – – –
HighTower Advisors
7
HighTower Advisors
Illinois
$57K +$9.4K +37 +16%
Northern Trust
8
Northern Trust
Illinois
$49K +$47.2K +186 +404%
VF
9
Virtu Financial
New York
$34K +$19.1K +75 +89%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$28K -$211K -831 -86%
Citadel Advisors
11
Citadel Advisors
Florida
$22K -$43.7K -172 -63%
LCM
12
LVM Capital Management
Michigan
$9K -$7.62K -30 -41%
TRCT
13
Tower Research Capital (TRC)
New York
$8K +$6.35K +25 +208%
Bank of America
14
Bank of America
North Carolina
$1K +$1.02K +4 New
Two Sigma Investments
15
Two Sigma Investments
New York
– -$195K -607 Closed
UBS Group
16
UBS Group
Switzerland
– -$43K -135 Closed
PCM
17
Penserra Capital Management
California
– -$27K -105 Closed
Wells Fargo
18
Wells Fargo
California
– +$254 +1 New

ARTL Hedge Fund Activity: Q3 2021 in Review

15 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q3 2021, worth a combined $1.57M — down 52% from $3.29M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ARTL and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.

The largest buyer was Northern Trust, adding an estimated $47.2K. The largest seller was Renaissance Technologies, cutting an estimated $258K.

  • 15 institutional investors held Artelo Biosciences (ARTL) as of Q3 2021, down from 16 in Q2 2021.
  • Funds reported $1.57M of Artelo Biosciences stock for Q3 2021, down 52% quarter-over-quarter.
  • 2 funds opened new Artelo Biosciences positions in Q3 2021 and 3 closed out, a net change of -1 holder.
  • The largest Artelo Biosciences buyer in Q3 2021 was Northern Trust, an estimated $47.2K added.
  • The largest Artelo Biosciences seller in Q3 2021 was Renaissance Technologies, an estimated $258K sold.

Based on aggregated 13F filings for Q3 2021.